Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    "CT-011" [TREATMENT] | lymphoma OR CLL
Show Display Options
Rank Status Study
1 Completed
Has Results
Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
Condition: Lymphoma
Interventions: Drug: CT-011;   Drug: Rituximab
2 Completed
Has Results
CT-011 MAb in DLBCL Patients Following ASCT
Conditions: Lymphoma, Large Cell, Diffuse;   Lymphoma, Mixed Cell, Diffuse;   Primary Mediastinal Large B-Cell Lymphoma
Intervention: Drug: CT-011
3 Active, not recruiting Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
Conditions: Stage III Diffuse Large B-Cell Lymphoma;   Stage IV Diffuse Large B-Cell Lymphoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pidilizumab

Study has passed its completion date and status has not been verified in more than two years.